Cited 0 time in
Downregulation of KLF4 and the Bcl-2/Bax ratio in advanced epithelial ovarian cancer
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Yoon, Ok | - |
| dc.contributor.author | Roh, Jaesook | - |
| dc.date.accessioned | 2022-07-16T12:57:32Z | - |
| dc.date.available | 2022-07-16T12:57:32Z | - |
| dc.date.issued | 2012-11 | - |
| dc.identifier.issn | 1792-1074 | - |
| dc.identifier.issn | 1792-1082 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/164302 | - |
| dc.description.abstract | Kruppel-like factor 4 (KLF4) is a key transcriptional regulator of cell differentiation and proliferation and an altered expression of KLF4 has been reported in a number of human malignancies. In the present study, we investigated KLF4 expression and its role in cell proliferation in advanced epithelial ovarian cancer (FOC). We compared KLF4, Bcl-2 and Bax transcript levels in ovaries isolated from advanced EOC and normal control ovaries. In addition, the KLF4 gene was transduced into ovarian cancer cells and transcript levels of Bcl-2 and Bax and cell proliferation were analyzed by real-time RT-PCR and MTT assays, respectively. Ovarian KLF4 expression and Bcl-2/Bax ratios were downregulated in most cases of advanced EOC. In addition, KLF4 overexpression in ovarian cancer cells increased the Bcl-2/Bax ratio. However, MTT analysis indicated that the overexpression of KLF4 had no effect on the proliferation of ovarian cancer cells. The inactivation of KLF4 is frequently observed in ovarian cancers and a reduced expression of KLF4 in the ovarian cancers may lead to a reduction in the Bcl-2/Bax ratio. The latter has a role in predicting cancer grade, although its exact role in ovarian carcinogenesis requires clarification. | - |
| dc.format.extent | 4 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Spandidos Publications | - |
| dc.title | Downregulation of KLF4 and the Bcl-2/Bax ratio in advanced epithelial ovarian cancer | - |
| dc.type | Article | - |
| dc.publisher.location | 그리이스 | - |
| dc.identifier.doi | 10.3892/ol.2012.834 | - |
| dc.identifier.scopusid | 2-s2.0-84866114888 | - |
| dc.identifier.wosid | 000310040300036 | - |
| dc.identifier.bibliographicCitation | Oncology Letters, v.4, no.5, pp 1033 - 1036 | - |
| dc.citation.title | Oncology Letters | - |
| dc.citation.volume | 4 | - |
| dc.citation.number | 5 | - |
| dc.citation.startPage | 1033 | - |
| dc.citation.endPage | 1036 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.subject.keywordPlus | BREAST-CANCER | - |
| dc.subject.keywordPlus | EXPRESSION | - |
| dc.subject.keywordPlus | GENE | - |
| dc.subject.keywordPlus | GROWTH | - |
| dc.subject.keywordPlus | BAX | - |
| dc.subject.keywordPlus | CELLS | - |
| dc.subject.keywordPlus | P21 | - |
| dc.subject.keywordAuthor | KLF4 | - |
| dc.subject.keywordAuthor | Bcl-2 | - |
| dc.subject.keywordAuthor | Bax | - |
| dc.subject.keywordAuthor | epithelial ovarian cancer | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
